Clinical-pathological Characterization and Outcomes of Metastatic Urothelial Cancer in Latin America

NCT03942497 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 218

Last updated 2026-02-12

No results posted yet for this study

Summary

The LACOG 1518 study will characterize demographic and clinical-pathological profile of patients diagnosed with recurrent/ metastatic urothelial cancer in Latin America.

Conditions

  • Recurrent/Metastatic Urothelial Cancers

Sponsors & Collaborators

  • Janssen-Cilag Ltd.

    collaborator INDUSTRY
  • Latin American Cooperative Oncology Group

    lead OTHER

Principal Investigators

  • Gustavo Werutsky, MD · Latin American Cooperative Oncology Group

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-01
Primary Completion
2021-08-31
Completion
2022-02-28

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03942497 on ClinicalTrials.gov